Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Сен. 17, 2024
Background
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
characterized
by
progressive
decline
in
cognitive
function,
which
significantly
increases
pain
and
social
burden.
However,
few
therapeutic
interventions
are
effective
preventing
or
mitigating
the
progression
of
AD.
An
increasing
number
recent
studies
support
hypothesis
that
gut
microbiome
its
metabolites
may
be
associated
with
upstream
regulators
AD
pathology.
Methods
In
this
review,
we
comprehensively
explore
potential
mechanisms
currently
available
targeting
for
improvement
Our
discussion
structured
around
modern
research
advancements
AD,
bidirectional
communication
between
brain,
multi-target
regulatory
effects
microbial
on
strategies
aimed
at
modulating
microbiota
to
manage
Results
The
plays
crucial
role
pathogenesis
through
continuous
via
microbiota-gut-brain
axis.
Among
these,
such
as
lipids,
amino
acids,
bile
acids
neurotransmitters,
especially
sphingolipids
phospholipids,
serve
central
components
gut-brain
axis,
regulating
AD-related
pathogenic
including
β-amyloid
metabolism,
Tau
protein
phosphorylation,
neuroinflammation.
Additionally,
probiotic
administration,
fecal
transplantation,
antibiotic
use
have
also
provided
evidence
supporting
association
At
same
time,
propose
an
innovative
strategy
treating
AD:
healthy
lifestyle
combined
targeted
probiotics
other
interventions,
aiming
restore
intestinal
ecology
balance.
Conclusion
Despite
previous
efforts,
molecular
microbes
act
yet
fully
described.
microorganisms
become
essential
target
connecting
axis
improving
symptoms
it
requires
joint
exploration
multiple
centers
disciplines.
Neurobiology of Disease,
Год журнала:
2024,
Номер
191, С. 106402 - 106402
Опубликована: Янв. 4, 2024
Social
dominance
is
a
universal
phenomenon
among
grouped
animals
that
profoundly
affects
survival,
health,
and
reproductive
success
by
determining
access
to
resources,
exerting
powerful
influence
on
subsequent
behavior.
However,
the
understanding
of
pain
anxiety
comorbidities
in
dominant
or
subordinate
suffering
from
chronic
not
well-defined.
Here,
we
provide
evidence
mice
are
more
susceptible
pain-induced
compared
mice.
We
propose
gut
microbiota
may
play
mediating
role
this
mechanism.
Our
findings
demonstrate
transplantation
fecal
with
inflammatory
pain,
but
mice,
into
antibiotics-treated
pseudo-germ-free
significantly
amplifies
anxiety-like
phenotypes,
highlighting
critical
involvement
behavioral
response.
Using
model,
carried
out
16S
rRNA
sequencing
untargeted
metabolomic
analyses
explore
relationship
between
metabolites
stable
social
hierarchy
Interestingly,
behaviors
were
directly
associated
some
microbial
genera
metabolites,
especially
bile
acid
metabolism.
Overall,
have
demonstrated
close
status
susceptibility,
contributions
high-anxiety
state
pain.
Pharmacological Research,
Год журнала:
2024,
Номер
unknown, С. 107080 - 107080
Опубликована: Янв. 1, 2024
Thanks
to
the
advancements
in
bioinformatics,
drugs,
and
other
interventions
that
modulate
microbes
treat
diseases
have
been
emerging
continuously.
In
recent
years,
an
increasing
number
of
databases
related
traditional
Chinese
medicine
(TCM)
gut
established.
However,
a
database
combining
two
has
not
yet
developed.
To
accelerate
TCM
research
address
micro
ecological
system
connection
between
short
board,
we
developed
most
comprehensive
micro-ecological
TCM.
This
initiative
includes
standardization
following
advantages:
(1)
A
repeatable
process
achieved
through
retrieval
strategy
identify
literature.
involved
identifying
419
experiment
articles
from
PubMed
six
authoritative
databases;
(2)
High-quality
data
integration
double-entry
extraction
literature,
mitigating
uncertainties
associated
with
natural
language
extraction;
(3)
Implementation
similar
aiding
prediction
mechanisms
action.
Leveraging
drug
similarity,
target
entity
known
drug-target
association,
our
platform
enables
effects
new
or
acupoint
prescription
using
existing
data.
total,
MicrobeTCM
171
diseases,
725
microbes,
1468
herb-formulas,
1032
herbs,
15780
chemical
compositions,
35
acupoint-formulas,
77
acupoints.
For
further
exploration,
please
visit
https://www.microbetcm.com.
Microbiome
studies
have
revealed
gut
microbiota's
potential
impact
on
complex
diseases.
However,
many
often
focus
one
disease
per
cohort.
We
developed
a
meta-analysis
workflow
for
microbiome
profiles
and
analyzed
shotgun
metagenomic
data
covering
11
Using
interpretable
machine
learning
differential
abundance
analysis,
our
findings
reinforce
the
generalization
of
binary
classifiers
Crohn's
(CD)
colorectal
cancer
(CRC)
to
hold-out
cohorts
highlight
key
microbes
driving
these
classifications.
identified
high
microbial
similarity
in
pairs
like
CD
vs
ulcerative
colitis
(UC),
CRC,
Parkinson's
type
2
diabetes
(T2D),
schizophrenia
T2D.
also
found
strong
inverse
correlations
Alzheimer's
UC.
These
findings,
detected
by
pipeline,
provide
valuable
insights
into
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Сен. 17, 2024
Background
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
characterized
by
progressive
decline
in
cognitive
function,
which
significantly
increases
pain
and
social
burden.
However,
few
therapeutic
interventions
are
effective
preventing
or
mitigating
the
progression
of
AD.
An
increasing
number
recent
studies
support
hypothesis
that
gut
microbiome
its
metabolites
may
be
associated
with
upstream
regulators
AD
pathology.
Methods
In
this
review,
we
comprehensively
explore
potential
mechanisms
currently
available
targeting
for
improvement
Our
discussion
structured
around
modern
research
advancements
AD,
bidirectional
communication
between
brain,
multi-target
regulatory
effects
microbial
on
strategies
aimed
at
modulating
microbiota
to
manage
Results
The
plays
crucial
role
pathogenesis
through
continuous
via
microbiota-gut-brain
axis.
Among
these,
such
as
lipids,
amino
acids,
bile
acids
neurotransmitters,
especially
sphingolipids
phospholipids,
serve
central
components
gut-brain
axis,
regulating
AD-related
pathogenic
including
β-amyloid
metabolism,
Tau
protein
phosphorylation,
neuroinflammation.
Additionally,
probiotic
administration,
fecal
transplantation,
antibiotic
use
have
also
provided
evidence
supporting
association
At
same
time,
propose
an
innovative
strategy
treating
AD:
healthy
lifestyle
combined
targeted
probiotics
other
interventions,
aiming
restore
intestinal
ecology
balance.
Conclusion
Despite
previous
efforts,
molecular
microbes
act
yet
fully
described.
microorganisms
become
essential
target
connecting
axis
improving
symptoms
it
requires
joint
exploration
multiple
centers
disciplines.